Key Takeaways
- Corteva and Hexagon Bio have formed a multi-million-dollar joint venture focused on nature-inspired crop protection.
- The JV is Corteva’s first collaboration originating from the pharmaceutical sector and Hexagon Bio’s first in agriculture.
- The partnership combines Corteva’s crop protection expertise with Hexagon Bio’s natural-product discovery platform.
- The collaboration aims to accelerate discovery of new modes of action for agricultural use.
- The JV was established through Corteva Catalyst, the company’s investment and collaboration platform.
Corteva Partners With Hexagon Bio on Nature-Inspired Crop Protection
Corteva (NYSE: CTVA), a global agricultural technology company, and Hexagon Bio, a biotechnology company focused on natural-product discovery, have announced the formation of a multi-million-dollar joint venture to accelerate the development of new crop protection solutions inspired by nature.
The joint venture marks the first agriculture-focused collaboration for Hexagon Bio and Corteva’s first joint venture originating from the pharmaceutical industry. The partnership is designed to advance discovery pipelines across agriculture while allowing each company to continue pursuing its core markets.
“Our partnership with Hexagon Bio expands our discovery engine, taking our crop protection innovation to the next level,” said Sam Eathington, Chief Technology and Digital Officer at Corteva. “As demand for nature-inspired solutions continues to grow, this collaboration allows us to move faster and think bigger.”
